Drug intelligence / Profile preview

chamomile tincture

Development stage: Phase 1
Administration: Oral, Topical

Overview

Chamomile tincture is a liquid herbal extract made from chamomile flowers (typically Matricaria recutita or Chamaemelum nobile). It contains active compounds including sesquiterpenes, flavonoids, and essential oils. The tincture is used medicinally for anxiety, digestive disorders, inflammation, pain relief, and sleep issues. It's typically prepared in a 1:5 concentration with 45% alcohol.

Other names: chamomilla tincture

Targets

BZD site (GABA-A receptor benzodiazepine site)

Beyond the preview

Go deeper on chamomile tincture.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on chamomile tincture.

Explore the full profile